Literature DB >> 10529380

Human serum immunoglobulin G3 subclass bound preferentially to asialo-, agalactoimmunoglobulin A1/Sepharose.

H Iwase1, Y Yokozeki, Y Hiki, A Tanaka, T Kokubo, T Sano, I Ishii-Karakasa, K Hisatani, Y Kobayashi, K Hotta.   

Abstract

As we reported before, exoglycosidase treatment of human serum IgA1 changed it to a sticky molecule. In order to examine the presence of the specific binding protein to the sticky IgA1 in human serum, IgA1, asialo-IgA1 (IgA1-S) and asialo-, agalacto-IgA1 (IgA1-SG)/Sepharose column chromatography of normal human serum was carried out. Purified hinge glycopeptide (HGP33) prepared from IgA1 was used for the preparation of HGP/Sepharose. A portion of the serum protein was bound to those columns and eluted with the buffer containing 1.0 M NaCl. About four times the amount of protein was eluted from the IgA1-SG/Sepharose column than that from IgA1/Sepharose. Most of the eluted protein was IgG, and the IgG1 and IgG3 subclasses but neither IgG2 nor IgG4 was dominant. Under the lower salt concentration, a portion of IgG was also bound to the HGP-SG/Sepharose column. The obtained results coincide well with the previous report of the co-present of IgG1 and IgG3 with deposited IgA1 in IgA nephropathy patients (Aucouturier, P., et al. (1989) Clin. Immunol. Immunopathol. 51, 338-347). Thus, the results solved the question of why the IgG3 was co-present with deposited IgA1 in IgA nephropathy patients. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10529380     DOI: 10.1006/bbrc.1999.1369

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  T cell cytokines determine the severity of experimental IgA nephropathy by regulating IgA glycosylation.

Authors:  S R Chintalacharuvu; N U Nagy; N Sigmund; J G Nedrud; M E Amm; S N Emancipator
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

Review 2.  Glycosylation of IgA1 and pathogenesis of IgA nephropathy.

Authors:  Jan Novak; Bruce A Julian; Jiri Mestecky; Matthew B Renfrow
Journal:  Semin Immunopathol       Date:  2012-03-21       Impact factor: 9.623

3.  Differential binding characteristics of native monomeric and polymeric immunoglobulin A1 (IgA1) on human mesangial cells and the influence of in vitro deglycosylation of IgA1 molecules.

Authors:  Y-H Gao; L-X Xu; J-J Zhang; Y Zhang; M-H Zhao; H-Y Wang
Journal:  Clin Exp Immunol       Date:  2007-03-26       Impact factor: 4.330

4.  Abnormal glycosylation of serum IgG in patients with IgA nephropathy.

Authors:  Hideki Homma; Keiichi Tozawa; Takahiro Yasui; Yasunori Itoh; Yutaro Hayashi; Kenjiro Kohri
Journal:  Clin Exp Nephrol       Date:  2006-09       Impact factor: 2.801

Review 5.  Immunopathogenesis of IgAN.

Authors:  Jonathan Barratt; Alice C Smith; Karen Molyneux; John Feehally
Journal:  Semin Immunopathol       Date:  2007-09-13       Impact factor: 9.623

6.  Self-aggregated deglycosylated IgA1 with or without IgG were associated with the development of IgA nephropathy.

Authors:  Y Yan; L-X Xu; J-J Zhang; Y Zhang; M-H Zhao
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

Review 7.  O-linked oligosaccharides of the IgA1 hinge region: roles of its aberrant structure in the occurrence and/or progression of IgA nephropathy.

Authors:  Yoshiyuki Hiki
Journal:  Clin Exp Nephrol       Date:  2009-04-15       Impact factor: 2.801

Review 8.  Pathogenesis of IgA Nephropathy: Current Understanding and Implications for Development of Disease-Specific Treatment.

Authors:  Barbora Knoppova; Colin Reily; R Glenn King; Bruce A Julian; Jan Novak; Todd J Green
Journal:  J Clin Med       Date:  2021-09-29       Impact factor: 4.241

Review 9.  The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy.

Authors:  Barbora Knoppova; Colin Reily; Nicolas Maillard; Dana V Rizk; Zina Moldoveanu; Jiri Mestecky; Milan Raska; Matthew B Renfrow; Bruce A Julian; Jan Novak
Journal:  Front Immunol       Date:  2016-04-12       Impact factor: 7.561

10.  Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA1 Antibody in IgA Nephropathy Patients.

Authors:  Yen-Ling Chiu; Wei-Chou Lin; Kai-Hsiang Shu; Yi-Wen Fang; Fan-Chi Chang; Yu-Hsiang Chou; Ching-Fang Wu; Wen-Chih Chiang; Shuei-Liong Lin; Yung-Ming Chen; Ming-Shiou Wu
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.